Tag: ACC 2026
SirPAD: Primary results confirm safety and efficacy of sirolimus-coated balloon in PAD
In the SirPAD trial, angioplasty with sirolimus-coated balloons led to a lower incidence of majo...
Clinical trial finds comparable performance between TAVI embolic protection devices
Results from the PROTECT H2H trial, a global clinical study comparing two embolic protection dev...
Roxana Mehran named ACC president
The American College of Cardiology (ACC) has named the influential interventional cardiologist a...
LAA closure device non-inferior to blood thinners in lowering stroke risk and death for some AF patients
For patients with non-valvular atrial fibrillation (AF) who had no contraindications to taking o...
Performance of AI-powered physiologic assessment tool shows promise in ALL-RISE trial
An artificial intelligence (AI)-powered tool for physiologic assessment during percutaneous coro...
FAST III confirms non-inferiority of vFFR to wire-based lesion assessment
Results of the FAST III trial have demonstrated the non-inferiority of coronary revascularisatio...
Evolocumab reduces risk of cardiac events in patients with no known atherosclerosis and diabetes
The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by ...
HI-PEITHO finds catheter-based procedure improves pulmonary embolism outcomes
Patients who underwent ultrasound-facilitated, catheter-directed fibrinolysis for acute pulmonar...
